PULM

Pulmatrix, Inc. PULM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PULM BPTH GYRE CRVO CAPR NXTC IDXG HTGMQ BNTC
6M -11.67 % -52.86 % 5.85 % -4.00 % -23.68 % 90.54 % -27.68 % 0.00 % 18.13 %
YTD -37.65 % -94.26 % -33.67 % 265.47 % -52.61 % -32.56 % -63.16 % 0.00 % 23.51 %
1Y 126.07 % -94.16 % -40.33 % -40.73 % -63.79 % -60.42 % -50.94 % -66.67 % 46.85 %
3Y 37.86 % -99.90 % -10.06 % -6.21 % 14.72 % -80.42 % -48.34 % -99.98 % 225.05 %
5Y -79.79 % -99.92 % -88.92 % -87.22 % 44.69 % -95.19 % -67.24 % -100.00 % -70.05 %
10Y -99.43 % -100.00 % -99.36 % -99.99 % -84.42 % -97.22 % -99.36 % -100.00 % -99.11 %
From the beginning -99.87 % -100.00 % -99.94 % -100.00 % -98.42 % -97.22 % -99.95 % -100.00 % -99.75 %

Dividend

Gyre Therapeutics, Inc.

Benitec Biopharma Inc.